SPS
TXG icon

Susquehanna Portfolio Strategies’s 10x Genomics TXG Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-298,230
Closed -$6.33M – 1072
2026
Q1 		$6.33M Hold
298,230
– – 0.09% 268
2025
Q4 		$4.86M Hold
298,230
– – 0.08% 306
2025
Q3 		$3.49M Hold
298,230
– – 0.06% 376
2025
Q2 		$3.45M Buy
+298,230
New +$2.72M 0.08% 276

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Susquehanna Portfolio Strategies's TXG Position: Q2 2026 in Review

Susquehanna Portfolio Strategies sold out of 10x Genomics (TXG) in Q2 2026, closing a stake of 298,230 shares — an estimated $6.33M sold.

Susquehanna Portfolio Strategies first reported a position in TXG in Q2 2025 and held it in 4 quarters. The position peaked at $6.33M in Q1 2026. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Susquehanna Portfolio Strategies reported no remaining 10x Genomics position as of Q2 2026 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 298,230 10x Genomics shares in Q2 2026, an estimated $6.33M.
  • Susquehanna Portfolio Strategies first reported a position in 10x Genomics in Q2 2025 and held it in 4 quarters.
  • Susquehanna Portfolio Strategies's 10x Genomics position peaked at $6.33M in Q1 2026.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.